News

Welsh Government adopts Dementia Action Plan

15 February 2018 — The Welsh Government has adopted the Dementia Action Plan for Wales 2018-2022, outlining a comprehensive response to the impact of dementia, including improving support of those affected and enabling dementia friendly communities. [read more]

Boehringer Ingelheim continues search for Alzheimer’s treatment despite trial set-back

20 February 2018 – Boehringer Ingelheim have shifted their attention to a new compound to treat Alzheimer’s disease, after topline results of two Phase II trials of BI 409306 showed that it did not have efficacy when tested for Alzheimer’s disease. [read more]

Merck remain committed after discontinuing Verubecestat study

14 February 2018 — Pharmaceutical company Merck have announced the discontinuation of Phase III studies into the effects of Verubecestat, a possible new drug treatment for Alzheimer’s disease. [read more]

Wendy Weidner appointed as Research and Policy Project Lead

06 February 2018 — Wendy will join ADI on 1 March and be responsible for ADI’s participation in the STRiDE (Strengthening responses to dementia in developing countries) project in partnership with the London School of Economics and Political Sciences (LSE). [read more]

Syndicate content